These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10999924

  • 21. Recent advances in maternal serum screening for Down syndrome.
    Messerlian GM, Canick JA.
    Med Health R I; 2002 Dec; 85(12):362-5. PubMed ID: 12593353
    [Abstract] [Full Text] [Related]

  • 22. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J, Skrablin S, Durić K, Suchanek E, Muzinić D, Kalafatić D, Kuvacić I, Zlopasa G, Plavec A.
    Lijec Vjesn; 2003 Dec; 125(3-4):55-60. PubMed ID: 12899094
    [Abstract] [Full Text] [Related]

  • 23. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy.
    Wallace EM.
    Br J Obstet Gynaecol; 1996 Nov; 103(11):1174-5. PubMed ID: 8917015
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter-Knill-Jones (S-KJ) approach.
    Hwa HL, Yen MF, Hsieh FJ, Ko TM, Chen TH.
    J Perinat Med; 2004 Nov; 32(5):407-12. PubMed ID: 15493716
    [Abstract] [Full Text] [Related]

  • 25. [Maternal serum screening for Down's syndrome].
    Muller F.
    Ann Biol Clin (Paris); 2002 Nov; 60(6):689-92. PubMed ID: 12446233
    [No Abstract] [Full Text] [Related]

  • 26. [Prenatal screening and diagnostics after infertility treatment].
    Gjerris AC, Loft A, Pinborg AB, Christiansen M, Tabor A.
    Ugeskr Laeger; 2007 Jan 29; 169(5):414-9. PubMed ID: 17280635
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. First-trimester screening for Down's syndrome.
    Wald NJ.
    N Engl J Med; 2004 Feb 05; 350(6):619-21; author reply 619-21. PubMed ID: 14762194
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K.
    Ann Clin Biochem; 2001 Jul 05; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract] [Full Text] [Related]

  • 36. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T, Ellis A, Jones R.
    Ann Clin Biochem; 2004 Nov 05; 41(Pt 6):464-8. PubMed ID: 15588435
    [Abstract] [Full Text] [Related]

  • 37. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec 05; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M, Høgdall EV, Larsen SO, Høgdall C.
    Prenat Diagn; 2002 May 05; 22(5):385-7. PubMed ID: 12001192
    [Abstract] [Full Text] [Related]

  • 40. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S, Hahnemann JM, Skibsted L, Jensen LN, Sperling L, Zingenberg H, Kristiansen A, Brøndum-Nielsen K.
    Ugeskr Laeger; 2008 Mar 31; 170(14):1152-6. PubMed ID: 18405480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.